Compound class:
Synthetic organic
Comment: cis-JB253 is described in [1]. The structure is based upon that of the diabetes sulfonylurea drug glimepiride. This compound is formed from trans-JB253 upon photoisomerization using blue light. This isomerization process is reversible. The molecule is active in the cis-state, increasing insulin production from pancreatic B-cells in vitro. It is postulated that this type of photoswitchable compound could in the future, allow better control of blood glucose in diabetic patients [1].
Note that the PubChem CID we link to does not specify the cis-trans state of the compound. |
|
References |
1. Broichhagen J, Schönberger M, Cork SC, Frank JA, Marchetti P, Bugliani M, Shapiro AM, Trapp S, Rutter GA, Hodson DJ et al.. (2014)
Optical control of insulin release using a photoswitchable sulfonylurea. Nat Commun, 5: 5116. [PMID:25311795] |
2. Picard A, Moullé VS, Le Foll C, Cansell C, Véret J, Coant N, Le Stunff H, Migrenne S, Luquet S, Cruciani-Guglielmacci C et al.. (2014)
Physiological and pathophysiological implications of lipid sensing in the brain. Diabetes Obes Metab, 16 Suppl 1: 49-55. [PMID:25200296] |
3. Tsuboi T, Rutter GA. (2003)
Multiple forms of "kiss-and-run" exocytosis revealed by evanescent wave microscopy. Curr Biol, 13 (7): 563-7. [PMID:12676086] |